Cargando…
Monoclonal Antibodies in Treating Food Allergy: A New Therapeutic Horizon
Food allergy (FA) is a pathological immune response, potentially deadly, induced by exposure to an innocuous and specific food allergen. To date, there is no specific treatment for FAs; thus, dietary avoidance and symptomatic medications represent the standard treatment for managing them. Recently,...
Autores principales: | Manti, Sara, Pecora, Giulia, Patanè, Francesca, Giallongo, Alessandro, Parisi, Giuseppe Fabio, Papale, Maria, Licari, Amelia, Marseglia, Gian Luigi, Leonardi, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308414/ https://www.ncbi.nlm.nih.gov/pubmed/34371821 http://dx.doi.org/10.3390/nu13072314 |
Ejemplares similares
-
Lower Airway Microbiota
por: Pulvirenti, Giulio, et al.
Publicado: (2019) -
Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review
por: Manti, Sara, et al.
Publicado: (2021) -
Type 2 inflammation in cystic fibrosis: New insights
por: Manti, Sara, et al.
Publicado: (2022) -
Food Allergies: Current and Future Treatments
por: Licari, Amelia, et al.
Publicado: (2019) -
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease
por: Manti, Sara, et al.
Publicado: (2022)